Raras
Buscar doenças, sintomas, genes...
NÃO RARA NA EUROPA: Hipodontia
ORPHA:2227CID-10 · K00.0DOENÇA RARA

É uma doença dos dentes em que um ou mais dentes não nascem ou não se formam, e por isso estão faltando na boca.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença dos dentes em que um ou mais dentes não nascem ou não se formam, e por isso estão faltando na boca.

🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: K00.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦷
Dentes
13 sintomas
🧬
Pele e cabelo
8 sintomas
😀
Face
8 sintomas
🫘
Rins
3 sintomas
👁️
Olhos
3 sintomas
💪
Músculos
2 sintomas

+ 16 sintomas em outras categorias

Características mais comuns

Intolerância ao calor
Agenesia dos dentes permanentes
Anormalidade dos dentes decíduos
Pelos corporais esparsos
Anodontia
Infecção do trato respiratório
57sintomas
Sem dados (57)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 57 características clínicas mais associadas, ordenadas por frequência.

Intolerância ao calorHeat intolerance
Agenesia dos dentes permanentesAgenesis of permanent teeth
Anormalidade dos dentes decíduosAbnormality of primary teeth
Pelos corporais esparsosSparse body hair
Anodontia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa11
Últimos 10 anos6publicações
Pico20182 papers
Linha do tempo
20202015Hoje · 2026📈 2018Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição.

LRP6Low-density lipoprotein receptor-related protein 6Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes (PubMed:11357136, PubMed:11448771, PubMed:15778503, PubMed:16341017, PubMed:16513652, PubMed:17326769, PubMed:17400545, PubMed:19107203, PubMed:19293931, PubMed:19801552, PubMed:28341812, PubMed:34896607). Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in various processes including retinal an

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulumMembrane raft

VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
MECANISMO DE DOENÇA

Coronary artery disease, autosomal dominant, 2

A common heart disease characterized by reduced or absent blood flow in one or more of the arteries that encircle and supply the heart. Its most important complication is acute myocardial infarction.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
29.6 TPM
Útero
28.5 TPM
Cervix Endocervix
24.6 TPM
Ovário
20.6 TPM
Aorta
19.7 TPM
OUTRAS DOENÇAS (4)
tooth agenesis, selective, 7tooth agenesisautosomal dominant hypohidrotic ectodermal dysplasiacoronary artery disease, autosomal dominant 2
HGNC:6698UniProt:O75581
IRF6Interferon regulatory factor 6Candidate gene tested inAltamente restrito
FUNÇÃO

Probable DNA-binding transcriptional activator. Key determinant of the keratinocyte proliferation-differentiation switch involved in appropriate epidermal development (By similarity). Plays a role in regulating mammary epithelial cell proliferation (By similarity). May regulate WDR65 transcription (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (2)
Interferon gamma signalingInterferon alpha/beta signaling
MECANISMO DE DOENÇA

Van der Woude syndrome 1

An autosomal dominant developmental disorder characterized by lower lip pits, cleft lip and/or cleft palate.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
188.7 TPM
Skin Sun Exposed Lower leg
170.2 TPM
Esôfago - Mucosa
122.4 TPM
Vagina
84.4 TPM
Glândula salivar
57.1 TPM
OUTRAS DOENÇAS (8)
autosomal dominant popliteal pterygium syndromevan der Woude syndrome 1van der Woude syndromecleft lip and alveolus
HGNC:6121UniProt:O14896
FGFR1Fibroblast growth factor receptor 1Candidate gene tested inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activati

LOCALIZAÇÃO

Cell membraneNucleusCytoplasm, cytosolCytoplasmic vesicle

VIAS BIOLÓGICAS (2)
Epithelial-Mesenchymal Transition (EMT) during gastrulationFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Pfeiffer syndrome

A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
144.8 TPM
Ovário
142.9 TPM
Artéria tibial
134.1 TPM
Fallopian Tube
122.3 TPM
Cérebro - Hemisfério cerebelar
122.0 TPM
OUTRAS DOENÇAS (20)
Hartsfield-Bixler-Demyer syndromeencephalocraniocutaneous lipomatosisosteoglophonic dysplasiaPfeiffer syndrome
HGNC:3688UniProt:P11362
TGFAProtransforming growth factor alphaCandidate gene tested inTolerante
FUNÇÃO

TGF alpha is a mitogenic polypeptide that is able to bind to the EGF receptor/EGFR and to act synergistically with TGF beta to promote anchorage-independent cell proliferation in soft agar

LOCALIZAÇÃO

Secreted, extracellular spaceCell membrane

VIAS BIOLÓGICAS (4)
COPII-mediated vesicle transportCargo concentration in the ERTFAP2 (AP-2) family regulates transcription of growth factors and their receptorsEstrogen-dependent gene expression
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
25.2 TPM
Esôfago - Mucosa
21.1 TPM
Skin Sun Exposed Lower leg
17.4 TPM
Skin Not Sun Exposed Suprapubic
16.2 TPM
Vagina
16.2 TPM
OUTRAS DOENÇAS (1)
tooth agenesis
HGNC:11765UniProt:P01135
SUMO1Small ubiquitin-related modifier 1Candidate gene tested inAltamente restrito
FUNÇÃO

Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repa

LOCALIZAÇÃO

Nucleus membraneNucleus speckleCytoplasmNucleus, PML bodyCell membraneNucleus

VIAS BIOLÓGICAS (4)
SUMO is proteolytically processedSUMO is conjugated to E1 (UBA2:SAE1)Regulation of IFNG signalingFormation of Incision Complex in GG-NER
MECANISMO DE DOENÇA

Non-syndromic orofacial cleft 10

A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
126.7 TPM
Linfócitos
116.2 TPM
Cérebro - Hemisfério cerebelar
113.1 TPM
Artéria tibial
83.5 TPM
Brain Frontal Cortex BA9
83.2 TPM
OUTRAS DOENÇAS (2)
orofacial cleft 10tooth agenesis
HGNC:12502UniProt:P63165
EDARADDEctodysplasin-A receptor-associated adapter proteinCandidate gene tested inTolerante
FUNÇÃO

Adapter protein that interacts with EDAR DEATH domain and couples the receptor to EDA signaling pathway during morphogenesis of ectodermal organs. Mediates the activation of NF-kappa-B

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
TNFs bind their physiological receptors
MECANISMO DE DOENÇA

Ectodermal dysplasia 11A, hypohidrotic/hair/nail type, autosomal dominant

A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. It is an autosomal dominant condition characterized by hypotrichosis, abnormal or missing teeth, and hypohidrosis due to the absence of sweat glands.

EXPRESSÃO TECIDUAL(Baixa expressão)
Skin Not Sun Exposed Suprapubic
3.2 TPM
Estômago
3.1 TPM
Tireoide
2.8 TPM
Testículo
2.6 TPM
Esôfago - Mucosa
2.6 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (5)
ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessiveectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominanttooth agenesisautosomal dominant hypohidrotic ectodermal dysplasia
HGNC:14341UniProt:Q8WWZ3
GREM2Gremlin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Cytokine that inhibits the activity of BMP2 and BMP4 in a dose-dependent manner, and thereby modulates signaling by BMP family members. Contributes to the regulation of embryonic morphogenesis via BMP family members. Antagonizes BMP4-induced suppression of progesterone production in granulosa cells

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Signaling by BMP
MECANISMO DE DOENÇA

Tooth agenesis, selective, 9

A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). STHAG9 inheritance is autosomal dominant.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
29.5 TPM
Cólon transverso
19.8 TPM
Intestino delgado
18.9 TPM
Fígado
12.8 TPM
Fibroblastos
12.6 TPM
OUTRAS DOENÇAS (2)
tooth agenesis, selective, 9tooth agenesis
HGNC:17655UniProt:Q9H772
TSPEARThrombospondin-type laminin G domain and EAR repeat-containing proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a critical role in tooth and hair follicle morphogenesis through regulation of the Notch signaling pathway (PubMed:27736875). May play a role in development or function of the auditory system (PubMed:22678063)

LOCALIZAÇÃO

SecretedCell surfaceCell projection, stereocilium

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 98

A form of non-syndromic sensorineural hearing loss with prelingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
7.2 TPM
Pituitária
4.3 TPM
Tireoide
2.5 TPM
Skin Not Sun Exposed Suprapubic
0.6 TPM
Intestino delgado
0.6 TPM
OUTRAS DOENÇAS (3)
tooth agenesis, selective, 10ectodermal dysplasia 14, hair/tooth type with or without hypohidrosisautosomal recessive nonsyndromic hearing loss 98
HGNC:1268UniProt:Q8WU66
WNT10AProtein Wnt-10aDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Ligand for members of the frizzled family of seven transmembrane receptors (Probable). Functions in the canonical Wnt/beta-catenin signaling pathway (By similarity). Plays a role in normal ectoderm development (PubMed:17847007, PubMed:28589954). Required for normal tooth development (PubMed:17847007, PubMed:28589954, PubMed:29178643). Required for normal postnatal development and maintenance of tongue papillae and sweat ducts (PubMed:28589954). Required for normal proliferation of basal cells in

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
MECANISMO DE DOENÇA

Odonto-onycho-dermal dysplasia

A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
63.0 TPM
Skin Not Sun Exposed Suprapubic
8.9 TPM
Skin Sun Exposed Lower leg
7.1 TPM
Esôfago - Mucosa
6.7 TPM
Pituitária
6.4 TPM
OUTRAS DOENÇAS (5)
tooth agenesis, selective, 4Schöpf-Schulz-Passarge syndromeodonto-onycho-dermal dysplasiatooth agenesis
HGNC:13829UniProt:Q9GZT5
EDAEctodysplasin-ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cytokine which is involved in epithelial-mesenchymal signaling during morphogenesis of ectodermal organs. Functions as a ligand activating the DEATH-domain containing receptors EDAR and EDA2R (PubMed:11039935, PubMed:27144394, PubMed:34582123, PubMed:8696334). May also play a role in cell adhesion (By similarity) Binds only to the receptor EDAR, while isoform 3 binds exclusively to the receptor EDA2R Binds only to the receptor EDA2R

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (1)
TNFs bind their physiological receptors
MECANISMO DE DOENÇA

Ectodermal dysplasia 1, hypohidrotic, X-linked

A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. It is the most common form of over 150 clinically distinct ectodermal dysplasias.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
8.1 TPM
Nervo tibial
7.0 TPM
Tireoide
6.9 TPM
Cervix Ectocervix
6.8 TPM
Ovário
6.4 TPM
OUTRAS DOENÇAS (3)
X-linked hypohidrotic ectodermal dysplasiatooth agenesis, selective, X-linked, 1tooth agenesis
HGNC:3157UniProt:Q92838
MSX1Homeobox protein MSX-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a transcriptional repressor (By similarity). Capable of transcription autoinactivation (By similarity). Binds to the consensus sequence 5'-C/GTAAT-3' in downstream activin regulatory elements (DARE) in the gene promoter, thereby repressing the transcription of CGA/alpha-GSU and GNRHR (By similarity). Represses transcription of myoblast differentiation factors (By similarity). Binds to core enhancer regions in target gene promoters of myoblast differentiation factors with binding specific

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Specification of the neural plate border
MECANISMO DE DOENÇA

Tooth agenesis, selective, 1

A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). STHAG1 can be associated with orofacial cleft in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
129.5 TPM
Cervix Ectocervix
81.9 TPM
Pituitária
38.2 TPM
Útero
33.1 TPM
Tecido adiposo
28.5 TPM
OUTRAS DOENÇAS (7)
tooth agenesis, selective, 1orofacial cleft 5tooth and nail syndromecleft lip and alveolus
HGNC:7391UniProt:P28360
PAX9Paired box protein Pax-9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor required for normal development of thymus, parathyroid glands, ultimobranchial bodies, teeth, skeletal elements of skull and larynx as well as distal limbs

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Tooth agenesis, selective, 3

A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth).

EXPRESSÃO TECIDUAL(Tecido-específico)
Esôfago - Mucosa
81.1 TPM
Glândula salivar
14.4 TPM
Vagina
6.6 TPM
Próstata
5.0 TPM
Pituitária
3.1 TPM
OUTRAS DOENÇAS (2)
tooth agenesis, selective, 3tooth agenesis
HGNC:8623UniProt:P55771
WNT10BProtein Wnt-10bDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Member of the Wnt ligand gene family that encodes for secreted proteins, which activate the Wnt signaling cascade. Specifically activates canonical Wnt/beta-catenin signaling and thus triggers beta-catenin/LEF/TCF-mediated transcriptional programs. Involved in signaling networks controlling stemness, pluripotency and cell fate decisions. Acts in the immune system, mammary gland, adipose tissue, bone and skin

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
MECANISMO DE DOENÇA

Split-hand/foot malformation 6

A limb malformation involving the central rays of the autopod and presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. Some patients have been found to have intellectual disability, ectodermal and craniofacial findings, and orofacial clefting.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
36.1 TPM
Córtex cerebral
29.0 TPM
Brain Frontal Cortex BA9
26.8 TPM
Brain Anterior cingulate cortex BA24
21.3 TPM
Brain Caudate basal ganglia
17.6 TPM
OUTRAS DOENÇAS (4)
tooth agenesis, selective, 8split hand-foot malformation 6tooth agenesissplit hand-foot malformation
HGNC:12775UniProt:O00744

Variantes genéticas (ClinVar)

945 variantes patogênicas registradas no ClinVar.

🧬 LRP6: GRCh38/hg38 12p13.33-11.1(chr12:64621-34650483)x3 ()
🧬 LRP6: NM_002336.3(LRP6):c.3550C>T (p.Arg1184Ter) ()
🧬 LRP6: GRCh38/hg38 12p13.33-q13.12(chr12:82453-49847230)x3 ()
🧬 LRP6: NM_002336.3(LRP6):c.3373C>T (p.Arg1125Ter) ()
🧬 LRP6: NM_002336.3(LRP6):c.55+1G>A ()
Ver todas no ClinVar

Vias biológicas (Reactome)

77 vias biológicas associadas aos genes desta condição.

TCF dependent signaling in response to WNT Negative regulation of TCF-dependent signaling by WNT ligand antagonists Disassembly of the destruction complex and recruitment of AXIN to the membrane Regulation of FZD by ubiquitination Signaling by RNF43 mutants Interferon gamma signaling Interferon alpha/beta signaling PI3K Cascade PIP3 activates AKT signaling Signaling by FGFR1 amplification mutants Signaling by activated point mutants of FGFR1 FGFR1b ligand binding and activation FGFR1c ligand binding and activation FGFR1c and Klotho ligand binding and activation Constitutive Signaling by Aberrant PI3K in Cancer NCAM signaling for neurite out-growth Signal transduction by L1 Phospholipase C-mediated cascade: FGFR1 Downstream signaling of activated FGFR1 SHC-mediated cascade:FGFR1 PI-3K cascade:FGFR1 FRS-mediated FGFR1 signaling Negative regulation of FGFR1 signaling Signaling by FGFR1 in disease RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Signaling by plasma membrane FGFR1 fusions Epithelial-Mesenchymal Transition (EMT) during gastrulation Formation of paraxial mesoderm Signaling by EGFR GRB2 events in EGFR signaling GAB1 signalosome SHC1 events in EGFR signaling EGFR downregulation COPII-mediated vesicle transport EGFR interacts with phospholipase C-gamma Inhibition of Signaling by Overexpressed EGFR Cargo concentration in the ER Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis TFAP2 (AP-2) family regulates transcription of growth factors and their receptors Extra-nuclear estrogen signaling Estrogen-dependent gene expression Estrogen-dependent nuclear events downstream of ESR-membrane signaling Developmental Lineage of Mammary Gland Luminal Epithelial Cells Developmental Lineage of Mammary Gland Myoepithelial Cells SUMO is conjugated to E1 (UBA2:SAE1) SUMO is transferred from E1 to E2 (UBE2I, UBC9) SUMO is proteolytically processed SUMOylation of DNA damage response and repair proteins SUMOylation of transcription factors SUMOylation of ubiquitinylation proteins SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of intracellular receptors SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins SUMOylation of DNA methylation proteins SUMOylation of immune response proteins Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Formation of Incision Complex in GG-NER Regulation of IFNG signaling Negative regulation of activity of TFAP2 (AP-2) family transcription factors Postmitotic nuclear pore complex (NPC) reformation Maturation of nucleoprotein Maturation of nucleoprotein SUMOylation of nuclear envelope proteins PKR-mediated signaling Transcriptional and post-translational regulation of MITF-M expression and activity Maturation of DENV proteins TNFs bind their physiological receptors Signaling by BMP WNT ligand biogenesis and trafficking Class B/2 (Secretin family receptors) Specification of the neural plate border Transcriptional regulation of white adipocyte differentiation

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — NÃO RARA NA EUROPA: Hipodontia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
0 papers (10 anos)
#1

[National protocol for the diagnosis and management of Axenfeld-Rieger syndrome: Summary for the primary care physician].

Journal francais d'ophtalmologie2026 Feb

Axenfeld-Rieger syndrome/anomaly (ARS) is a rare genetic disorder with an autosomal dominant inheritance pattern, characterized by dysgenesis of the anterior segment of the eye. It may present with systemic anomalies (Axenfeld-Rieger syndrome) or without (Axenfeld anomaly) and may sometimes be associated with multiple congenital malformations. The estimated prevalence ranges from 1 in 50,000 to 1 in 200,000 live births, with an approximate rate of 1 in 100,000, but no epidemiological studies have been conducted to date. A clinical diagnosis of Axenfeld-Rieger syndrome requires the presence of both Axenfeld and Rieger ocular anomalies, accompanied by extraocular systemic features. Ocular manifestations include iris abnormalities, posterior embryotoxon, juvenile-onset glaucoma (a common complication), and dysgenesis of the iridocorneal angle with iridocorneal adhesions. The most commonly observed systemic anomalies include: umbilical defects; craniofacial dysmorphism; dentofacial abnormalities, such as Class III malocclusion due to maxillary hypoplasia, oligodontia, dental malformations (taurodontism, root dysplasia), microdontia, hypodontia, and anodontia; hearing impairment (partial or complete sensorineural hearing loss); and cardiac anomalies, including non-congenital heart disease and mitral valve insufficiency. Additional anomalies may include hypospadias in males, anal stenosis, endocrine disorders (notably growth retardation) secondary to pituitary dysfunction, psychomotor delay, and various neurological malformations such as Dandy-Walker malformation, mega cisterna magna, posterior fossa cysts, cerebellar vermis hypoplasia, ventriculomegaly, aprosencephaly, cerebral atrophy, microcephaly, arteriovenous malformations (AVM), and digital anomalies such as camptodactyly. Diagnosis is typically made in infancy, based on iris anomalies such as corectopia (displacement of the pupil), polycoria (multiple pupils), and iris hypoplasia. Posterior embryotoxon is frequently observed upon slit-lamp examination. Given the clinical variability, a comprehensive pediatric assessment is essential to identify systemic anomalies and distinguish Axenfeld-Rieger syndrome from the isolated Axenfeld anomaly.

#2

Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark.

JAMA dermatology2024 May 01

Ectodermal dysplasias constitute a group of rare genetic disorders of the skin and skin appendages with hypodontia, hypotrichosis, and hypohidrosis as cardinal features. There is a lack of population-based research into the epidemiology of ectodermal dysplasias. To establish a validated population-based cohort of patients with ectodermal dysplasia in Denmark and to assess the disease prevalence and patient characteristics. This nationwide cohort study used individual-level registry data recorded across the Danish universal health care system to identify patients with ectodermal dysplasias from January 1, 1995, to August 25, 2021. A 3-level search of the Danish National Patient Registry and the Danish National Child Odontology Registry was conducted to identify patients with diagnosis codes indicative of ectodermal dysplasias; patients registered in the Danish RAREDIS Database, the Danish Database of Genodermatoses, and local databases were also added. The search results underwent diagnosis validation and review of clinical data using medical records. Of 844 patient records suggestive of ectodermal dysplasias, 791 patients (93.7%) had medical records available for review. Positive predictive values of the diagnosis coding were computed, birth prevalence was estimated, and patient characteristics were identified. Data analysis was performed from May 4 to December 22, 2023. The identified and validated study cohort included 396 patients (median [IQR] age at diagnosis, 13 [4-30] years, 246 females [62.1%]), of whom 319 had confirmed ectodermal dysplasias and 77 were likely cases. The combined positive predictive value (PPV) for ectodermal dysplasia-specific diagnosis codes was 67.0% (95% CI, 62.7%-71.0%). From 1995 to 2011, the estimated minimum birth prevalence per 100 000 live births was 14.5 (95% CI, 12.2-16.7) for all ectodermal dysplasias and 2.8 (95% CI, 1.8-3.8) for X-linked hypohidrotic ectodermal dysplasias. A molecular genetic diagnosis was available for 241 patients (61%), including EDA (n = 100), IKBKG (n = 55), WNT10A (n = 21), TRPS1 (n = 18), EDAR (n = 10), P63 (n = 9), GJB6 (n = 9), PORCN (n = 7), and other rare genetic variants. The findings of this nationwide cohort study indicate that the prevalence of ectodermal dysplasias was lower than previously reported. Furthermore, PPVs of the search algorithms emphasized the importance of diagnosis validation. The establishment of a large nationwide cohort of patients with ectodermal dysplasias, including detailed clinical and molecular data, is a unique resource for future research in ectodermal dysplasias.

#3

EDA, EDAR, EDARADD and WNT10A allelic variants in patients with ectodermal derivative impairment in the Spanish population.

Orphanet journal of rare diseases2019 Dec 03

Ectodermal dysplasias (ED) are a group of genetic conditions affecting the development and/or homeostasis of two or more ectodermal derivatives. An attenuated phenotype is considered a non-syndromic trait when the patient is affected by only one impaired ectodermal structure, such as in non-syndromic tooth agenesis (NSTA) disorder. Hypohidrotic ectodermal dysplasia (HED) is the most highly represented ED. X-linked hypohidrotic ectodermal dysplasia (XLHED) is the most common subtype, with an incidence of 1/50,000-100,000 males, and is associated with the EDA gene (Xq12-q13.1); the dominant and recessive subtypes involve the EDAR (2q13) and EDARADD (1q42.3) genes, respectively. The WNT10A gene (2q35) is associated more frequently with NSTA. Our goal was to determine the mutational spectrum in a cohort of 72 Spanish patients affected by one or more ectodermal derivative impairments referred to as HED (63/72) or NSTA (9 /72) to establish the prevalence of the allelic variants of the four most frequently associated genes. Sanger sequencing of the EDA, EDAR, EDARADD and WNT10A genes and multiplex ligation-dependent probe amplification (MLPA) were performed. A total of 61 children and 11 adults, comprising 50 males and 22 females, were included. The average ages were 5.4 and 40.2 years for children and adults, respectively. A molecular basis was identified in 51/72 patients, including 47/63 HED patients, for whom EDA was the most frequently involved gene, and 4/9 NSTA patients, most of whom had variants of WNT10A. Among all the patients, 37/51 had variants of EDA, 8/51 had variants of the WNT10A gene, 4/51 had variants of EDAR and 5/51 had variants of EDARADD. In 42/51 of cases, the variants were inherited according to an X-linked pattern (27/42), with the remaining showing an autosomal dominant (10/42) or autosomal recessive (5/42) pattern. Among the NSTA patients, 3/9 carried pathogenic variants of WNT10A and 1/9 carried EDA variants. A total of 60 variants were detected in 51 patients, 46 of which were different, and out of these 46 variants, 12 were novel. This is the only molecular study conducted to date in the Spanish population affected by ED. The EDA, EDAR, EDARADD and WNT10A genes constitute the molecular basis in 70.8% of patients with a 74.6% yield in HED and 44.4% in NSTA. Twelve novel variants were identified. The WNT10A gene has been confirmed as the second molecular candidate that has been identified and accounts for one-half of non-EDA patients and one-third of NSTA patients. Further studies using next generation sequencing (NGS) will help to identify other contributory genes in the remaining uncharacterized Spanish patients.

#4

WNT10A variants in relation to nonsyndromic hypodontia in eastern Slovak population.

Journal of genetics2018 Dec

Nonsyndromic hypodontia is a congenital absence of less than six permanent teeth, with a most common subtype maxillary lateral incisor agenesis (MLIA). Mutations in several genes have been described in severe tooth agenesis. The aim of this study was to search for the variants in wingless-type MMTV-integration site family member (WNT10A), paired box 9 (PAX9) and axis inhibitor 2 (AXIN2) genes, and investigate their potential role in the pathogenesis of non-syndromic hypodontia. Clinical examination and panoramic radiograph were performed in the cohort of 60 unrelated Slovak patients of Caucasian origin with nonsyndromic hypodontia including 37 MLIA cases and 48 healthy controls. Genomic DNA was isolated from buccal swabs and Sanger sequencing of WNT10A, PAX9 and AXIN2 was performed. Altogether, we identified 23 single-nucleotide variants, of which five were novel. We have found three rare nonsynonymous variants in WNT10A (p.Gly165Arg; p.Gly213Ser and p.Phe228Ile) in eight (13.33%) of 60 patients. Analysis showed potentially damaged WNT10A variant p.Phe228Ile predominantly occurred only in MLIA patients, and with a dominant form of tooth agenesis (odds ratio (ORdom) = 9.841; P = 0.045; 95% confidence interval (CI) 0.492-196.701;ORrec = 0.773; P = 1.000; 95% CI 0.015-39.877). In addition, the WNT10A variant p.Phe228Ile showed a trend associated with familial nonsyndromic hypodontia (P = 0.024; OR= 1.20; 95% CI 0.97-1.48). After Bonferroni correction, these effects remained with borderline tendencies. Using a 3D WNT10A protein model, we demonstrated that the variant Phe228Ile changes the proteinsecondary structure. In PAX9 and AXIN2, common variants were detected. Our findings suggest that the identified WNT10A variant p.Phe228Ile could represent risk for the inherited nonsyndromic hypodontia underlying MLIA. However, further study in different populations is required.

#5

Rare and Common Variants Conferring Risk of Tooth Agenesis.

Journal of dental research2018 May

We present association results from a large genome-wide association study of tooth agenesis (TA) as well as selective TA, including 1,944 subjects with congenitally missing teeth, excluding third molars, and 338,554 controls, all of European ancestry. We also tested the association of previously identified risk variants, for timing of tooth eruption and orofacial clefts, with TA. We report associations between TA and 9 novel risk variants. Five of these variants associate with selective TA, including a variant conferring risk of orofacial clefts. These results contribute to a deeper understanding of the genetic architecture of tooth development and disease. The few variants previously associated with TA were uncovered through candidate gene studies guided by mouse knockouts. Knowing the etiology and clinical features of TA is important for planning oral rehabilitation that often involves an interdisciplinary approach.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para NÃO RARA NA EUROPA: Hipodontia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para NÃO RARA NA EUROPA: Hipodontia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. [National protocol for the diagnosis and management of Axenfeld-Rieger syndrome: Summary for the primary care physician].
    Journal francais d'ophtalmologie· 2026· PMID 41455383mais citado
  2. Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark.
    JAMA dermatology· 2024· PMID 38477886mais citado
  3. EDA, EDAR, EDARADD and WNT10A allelic variants in patients with ectodermal derivative impairment in the Spanish population.
    Orphanet journal of rare diseases· 2019· PMID 31796081mais citado
  4. WNT10A variants in relation to nonsyndromic hypodontia in eastern Slovak population.
    Journal of genetics· 2018· PMID 30555066mais citado
  5. Rare and Common Variants Conferring Risk of Tooth Agenesis.
    Journal of dental research· 2018· PMID 29364747mais citado
  6. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  7. Patient Assessment Chronic Illness Care (PACIC) and its associations with quality of life among Swiss patients with systemic sclerosis: a mixed methods study.
    Orphanet J Rare Dis· 2023· PMID 36624535recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2227(Orphanet)
  2. MONDO:0005486(MONDO)
  3. GARD:16908(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q1549421(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

NÃO RARA NA EUROPA: Hipodontia
Compêndio · Raras BR

NÃO RARA NA EUROPA: Hipodontia

ORPHA:2227 · MONDO:0005486
CID-10
K00.0 · Anodontia
UMLS
C0020608
Wikidata
Wikipedia
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades